{"database": "openregs", "table": "documents", "rows": [["EPA-HQ-OAR-2002-0095-0019", "EPA", "EPA-HQ-OAR-2002-0095", "Letter from Paul Stolpman, Director, Office of Atmospheric Programs, EPA to essential Letter to Janet Woodcock M. D., Director of the Center for Drug Evaluation and Research, FDA requesting consultation on necessary CFCs for 2001 [A-93-39-VIII-B-3]", "Supporting & Related Material", "Letter", "2022-06-30T04:00:00Z", 2022, 6, null, null, "2022-07-01T03:08:14Z", null, 0, 0, "0900006483d7e6d9"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["EPA-HQ-OAR-2002-0095-0019"], "units": {}, "query_ms": 38.31353201530874, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}